UBQLN3 Antibodies

Santa Cruz Biotechnology features a diverse variety of UBQLN3 monoclonal antibodies for various research applications. UBQLN3 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). UBQLN3, or Ubiquilin 3, regulates protein degradation and cellular homeostasis by interacting with the ubiquitin-proteasome system. UBQLN3 facilitates the transport and degradation of misfolded proteins, maintaining cellular function and preventing toxic protein accumulation. Research has shown that UBQLN3 dysregulation may contribute to various neurodegenerative diseases, emphasizing its significance in both fundamental research and therapeutic development. UBQLN3 expression patterns have been observed across different tissue types, providing insights into its biological functions. Understanding UBQLN3's role in protein quality control mechanisms continues to be an active area of investigation. Ongoing studies focus on mapping UBQLN3 interactions within cellular pathways. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of UBQLN3's role in health and disease.